hydroxychloroquine has been researched along with Skin Neoplasms in 13 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Skin Neoplasms: Tumors or cancer of the SKIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To characterise the incidence rate of skin cancer associated with methotrexate and hydroxychloroquine in older adults with rheumatoid arthritis (RA)." | 8.31 | Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort study. ( Chen, SK; Desai, RJ; Gautam, N; Glynn, RJ; He, M; Kim, SC; Lee, H; Vine, SM; Weinblatt, ME, 2023) |
| "A 45-year-old woman with generalized cutaneous pseudolymphoma of Spiegler-Fendt was successfully treated with hydroxychloroquine." | 7.66 | Treatment of cutaneous pseudolymphoma with hydroxychloroquine. ( Stoll, DM, 1983) |
| "Hydroxychloroquine was suspected of causing an anxiety/psychotic disorder in one patient." | 7.11 | A lead-in safety study followed by a phase 2 clinical trial of dabrafenib, trametinib and hydroxychloroquine in advanced BRAFV600 mutant melanoma patients previously treated with BRAF-/MEK-inhibitors and immune checkpoint inhibitors. ( Awada, G; Fasolino, G; Kruse, V; Neyns, B; Schwarze, JK; Tijtgat, J, 2022) |
| " Ulipristal for uterine fibroids : market withdrawal due to risk of severe liver injury." | 5.12 | [Pharmacovigilance update]. ( Ekobena, P; Ivanyuk, A; Livio, F, 2021) |
| "To characterise the incidence rate of skin cancer associated with methotrexate and hydroxychloroquine in older adults with rheumatoid arthritis (RA)." | 4.31 | Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort study. ( Chen, SK; Desai, RJ; Gautam, N; Glynn, RJ; He, M; Kim, SC; Lee, H; Vine, SM; Weinblatt, ME, 2023) |
| " Consequently, hydroxychloroquine and topical glucocorticoids therapy were initiated with reported improvement in pruritus, erythema, and scale." | 3.74 | Chronic cutaneous lupus erythematosus in vitiligo. ( Bossenbroek, NM; Johnson, H; Meehan, SA; Pomeranz, MK; Robles, M; Rosenman, K, 2008) |
| "A 45-year-old woman with generalized cutaneous pseudolymphoma of Spiegler-Fendt was successfully treated with hydroxychloroquine." | 3.66 | Treatment of cutaneous pseudolymphoma with hydroxychloroquine. ( Stoll, DM, 1983) |
| "Hydroxychloroquine was suspected of causing an anxiety/psychotic disorder in one patient." | 3.11 | A lead-in safety study followed by a phase 2 clinical trial of dabrafenib, trametinib and hydroxychloroquine in advanced BRAFV600 mutant melanoma patients previously treated with BRAF-/MEK-inhibitors and immune checkpoint inhibitors. ( Awada, G; Fasolino, G; Kruse, V; Neyns, B; Schwarze, JK; Tijtgat, J, 2022) |
| "Thalidomide treatment finally led to complete remission." | 1.36 | Disseminated cutaneous lymphoid hyperplasia of 12 years' duration triggered by vaccination. ( Beylot-Barry, M; Doutre, MS; Pham-Ledard, A; Vergier, B, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 6 (46.15) | 2.80 |
| Authors | Studies |
|---|---|
| Yumine, A | 1 |
| Tsuji, G | 1 |
| Awada, G | 1 |
| Schwarze, JK | 1 |
| Tijtgat, J | 1 |
| Fasolino, G | 1 |
| Kruse, V | 1 |
| Neyns, B | 1 |
| Lee, H | 1 |
| Chen, SK | 1 |
| Gautam, N | 1 |
| Vine, SM | 1 |
| He, M | 1 |
| Desai, RJ | 1 |
| Weinblatt, ME | 1 |
| Glynn, RJ | 1 |
| Kim, SC | 1 |
| Han, B | 1 |
| Liu, H | 1 |
| Wang, H | 1 |
| Mizuno, H | 1 |
| Takahagi, S | 1 |
| Morita, S | 1 |
| Kamegashira, A | 1 |
| Tanaka, A | 1 |
| Ekobena, P | 1 |
| Ivanyuk, A | 1 |
| Livio, F | 1 |
| Gardair Bouchy, C | 1 |
| Kerdraon, R | 1 |
| Kluger, N | 1 |
| Armingaud, P | 1 |
| Wakosa, A | 1 |
| Estève, E | 1 |
| Amann, VC | 1 |
| Dreier, J | 1 |
| Ignatova, D | 1 |
| Kamarashev, J | 1 |
| Kerl, K | 1 |
| Kempf, W | 1 |
| Pascolo, S | 1 |
| Dummer, R | 1 |
| Cozzio, A | 1 |
| Guenova, E | 1 |
| Johnson, H | 1 |
| Bossenbroek, NM | 1 |
| Rosenman, K | 1 |
| Meehan, SA | 1 |
| Robles, M | 1 |
| Pomeranz, MK | 1 |
| Pham-Ledard, A | 1 |
| Vergier, B | 1 |
| Doutre, MS | 1 |
| Beylot-Barry, M | 1 |
| Gupta, U | 1 |
| Barman, KD | 1 |
| Saify, K | 1 |
| Stoll, DM | 1 |
| Roenigk, HH | 1 |
| Lesowitz, SA | 1 |
2 reviews available for hydroxychloroquine and Skin Neoplasms
| Article | Year |
|---|---|
Idiopathic Cutaneous Pseudolymphoma Treated Successfully with Hydroxychloroquine: A Case Report and Literature Review.
Topics: Humans; Hydroxychloroquine; Pseudolymphoma; Skin Diseases; Skin Neoplasms | 2022 |
[Pharmacovigilance update].
Topics: Adenosine Monophosphate; Alanine; Cleft Lip; Contraindications, Drug; COVID-19 Drug Treatment; Cytok | 2021 |
1 trial available for hydroxychloroquine and Skin Neoplasms
| Article | Year |
|---|---|
A lead-in safety study followed by a phase 2 clinical trial of dabrafenib, trametinib and hydroxychloroquine in advanced BRAFV600 mutant melanoma patients previously treated with BRAF-/MEK-inhibitors and immune checkpoint inhibitors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Hydroxychloroquine; Imidazoles; Immune Check | 2022 |
10 other studies available for hydroxychloroquine and Skin Neoplasms
| Article | Year |
|---|---|
Hydroxychloroquine induces matrix metalloproteinase 1 expression and apoptosis in neurofibromatosis type 1 Schwann cells.
Topics: Antimalarials; Apoptosis; Benzamides; Cell Line, Tumor; Cell Proliferation; Collagen Type I, alpha 1 | 2021 |
Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort study.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; | 2023 |
A case of multiple nodular cutaneous B-cell pseudolymphoma successfully treated with glucocorticoid, methotrexate, and hydroxychloroquine.
Topics: Diagnosis, Differential; Glucocorticoids; Humans; Hydroxychloroquine; Methotrexate; Pseudolymphoma; | 2022 |
[Cutaneous lymphoid hyperplasia (pseudolymphoma) on the red dye of a tattoo].
Topics: Adrenal Cortex Hormones; Adult; Biopsy; Coloring Agents; Diagnosis, Differential; Drug Eruptions; Ge | 2013 |
Disseminated Primary Cutaneous CD8+ Small/Medium-sized Pleomorphic T-cell Lymphoma Responding to Hydroxychloroquine.
Topics: Antimalarials; Biopsy, Needle; CD8 Antigens; Dose-Response Relationship, Drug; Drug Administration S | 2015 |
Chronic cutaneous lupus erythematosus in vitiligo.
Topics: Autoimmunity; Carcinoma, Squamous Cell; Clobetasol; Diabetes Complications; Diagnostic Errors; Drug | 2008 |
Disseminated cutaneous lymphoid hyperplasia of 12 years' duration triggered by vaccination.
Topics: Adolescent; B-Lymphocytes; CD3 Complex; Cyclins; DNA-Binding Proteins; Female; Hepatitis B Vaccines; | 2010 |
Squamous cell carcinoma complicating an untreated chronic discoid lupus erythematosus (CDLE) lesion in a black female.
Topics: Adult; Biopsy, Needle; Black People; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Comb | 2005 |
Treatment of cutaneous pseudolymphoma with hydroxychloroquine.
Topics: Diagnosis, Differential; Female; Humans; Hydroxychloroquine; Lymphoma; Middle Aged; Skin Neoplasms | 1983 |
Lymphocytoma cutis.
Topics: Humans; Hydroxychloroquine; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Skin Neopl | 1970 |